InvestorsHub Logo
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Re: Rymankoly post# 2394

Sunday, 10/06/2013 1:32:00 PM

Sunday, October 06, 2013 1:32:00 PM

Post# of 4817
Lantus has 80% of the long-acting insulin market & $5 billion in annual sales. Levemir has struggled to gain market acceptance & there's a number of new competitors in addition to an improved Lantus formulation coming down the path.